Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Non-Hodgkin-Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03590574
What this trial is testing

Phase I/II Study Evaluating AUTO4 in Patients With T Cell Receptor Beta Constant (TRBC)1 Positive T Cell Lymphoma

Who this might be right for
T Cell Non-Hodgkin LymphomaPeripheral T-Cell Lymphoma, Not Otherwise SpecifiedAngioimmunoblastic T-cell Lymphoma+1 more
Autolus Limited 20
Early research (Phase 1)Study completedNCT00392691
What this trial is testing

Melphalan, Yttrium Y 90 Ibritumomab Tiuxetan, and Rituximab Followed by Autologous Stem Cell Transplant in Treating Older Patients With Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment

Who this might be right for
Lymphoma
Swiss Cancer Institute 20
Testing effectiveness (Phase 2)Looking for participantsNCT06137118
What this trial is testing

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

Who this might be right for
B-cell Acute Lymphoblastic Leukemia (B-ALL)
AstraZeneca 255
Not applicableLooking for participantsNCT06618313
What this trial is testing

One Trial to Evaluate the Safety, Tolerability and Efficacy of JCXH-213 in Patients With r/r B-NHL

Who this might be right for
B-Cell Non-Hodgkin Lymphoma-RecurrentB-Cell Non-Hodgkin Lymphoma-Refractory
Beijing GoBroad Hospital 8
Early research (Phase 1)Looking for participantsNCT05077527
What this trial is testing

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

Who this might be right for
AIDS-Related Diffuse Large B-cell LymphomaAIDS-Related Non-Hodgkin LymphomaHIV Infection+12 more
AIDS Malignancy Consortium 20
Early research (Phase 1)Ended earlyNCT03893682
What this trial is testing

CG-806 in Patients With Relapsed or Refractory CLL/SLL or Non-Hodgkin's Lymphomas

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaNon-Hodgkin's Lymphoma
Aptose Biosciences Inc. 36
Testing effectiveness (Phase 2)UnknownNCT00807196
What this trial is testing

Zevalin With Non Myeloablative Allogeneic Stem Cell Transplantation in Patients With Non Hodgkin Lymphoma

Who this might be right for
Non-Hodgkins Lymphoma
Maisonneuve-Rosemont Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT03136146
What this trial is testing

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia

Who this might be right for
Recurrent Acute Lymphoblastic LeukemiaRecurrent Adult Lymphoblastic LymphomaRecurrent Burkitt Leukemia+8 more
M.D. Anderson Cancer Center 42
Early research (Phase 1)UnknownNCT03671460
What this trial is testing

CD19 CAR-T Cells for Patients With Relapse and Refractory CD19+ B-ALL.

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Tianjin Mycure Medical Technology Co., Ltd 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT03278782
What this trial is testing

Study of Pembrolizumab (MK-3475) in Combination With Romidepsin

Who this might be right for
Recurrent Anaplastic Large Cell LymphomaRecurrent Angioimmunoblastic T-Cell LymphomaRecurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma+8 more
M.D. Anderson Cancer Center 39
Testing effectiveness (Phase 2)WithdrawnNCT05152459
What this trial is testing

Tazemetostat in Combination With Umbralisib and Ublituximab for the Treatment Relapsed or Refractory Follicular Lymphoma

Who this might be right for
Recurrent Follicular LymphomaRefractory Follicular Lymphoma
City of Hope Medical Center
Large-scale testing (Phase 3)Looking for participantsNCT06742996
What this trial is testing

Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

Who this might be right for
Mantle Cell LymphomaB Cell Lymphoma
BeOne Medicines 300
Testing effectiveness (Phase 2)Study completedNCT00040846
What this trial is testing

Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+97 more
Fred Hutchinson Cancer Center 60
Early research (Phase 1)Study completedNCT01561833
What this trial is testing

A Pilot Study of Sorafenib Examining Biomarkers in Refractory or Relapsed T-Cell Lymphoma Patients

Who this might be right for
T Cell Lymphoma
Yale University 12
Testing effectiveness (Phase 2)Study completedNCT00513955
What this trial is testing

Combination Chemotherapy With or Without Bortezomib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

Who this might be right for
Lymphoma
University Hospital Plymouth NHS Trust 50
Testing effectiveness (Phase 2)Looking for participantsNCT07284433
What this trial is testing

Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies

Who this might be right for
Lymphoma Diffuse Large B-cellLeukemia and LymphomaLeukemia Relapse+1 more
AvenCell Therapeutics, Inc. 178
Large-scale testing (Phase 3)Study completedNCT00006348
What this trial is testing

Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+7 more
Alliance for Clinical Trials in Oncology 100
Early research (Phase 1)Study completedNCT04049825
What this trial is testing

Trial of OPB-111077 in Combination With Bendamustine and Rituximab in Patients With r/r DLBCL

Who this might be right for
Relapsed or Refractory Diffuse Large B-cell Lymphoma
Otsuka Pharmaceutical Co., Ltd. 36
Not applicableStudy completedNCT00293384
What this trial is testing

Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Barbara Ann Karmanos Cancer Institute 40
Large-scale testing (Phase 3)Active Not RecruitingNCT04680052
What this trial is testing

Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma.

Who this might be right for
Follicular LymphomaMarginal Zone Lymphoma
Incyte Corporation 654
Next Page